Preston Caldwell is senior U.S. economist for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, ...
The German government--the biggest shareholder in Commerzbank--said Friday that it won't offload any additional shares in the bank following the sale to UniCredit for 702 million euros ($783.5 million ...
Its main operations span iron ore and copper, with smaller contributions from metallurgical coal, thermal coal, and nickel. The company is also developing its Jansen potash project in Canada. BHP ...
Whitehaven's financial position is strong. Elevated coal prices have allowed the company to rapidly repay debt and improve its balance sheet, with Whitehaven moving from net debt of around AUD 810 ...
Rio Tinto is one of the world’s largest miners with operations in iron ore, aluminum (including bauxite and alumina), copper, and minerals (mineral sands, borates, salt and diamonds). Commodity demand ...
South32's alumina operations are in Australia and Brazil, and it also has aluminum operations in Brazil, South Africa, and Mozambique. Aluminum smelting and alumina refining assets are generally in ...
AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider.
We modestly reduce our fair value estimate for wide-moat Deterra Royalties to AUD 4.10 per share, down from AUD 4.20, due to lower iron ore prices.
An 85% stake in De Beers makes Anglo the world's largest diamond miner. As with platinum and palladium, there's big upside to Chinese diamond demand, which now stands at about 10% of the global total.
Stocks in Toronto pared some of the previous day's gains after the enthusiasm generated from the U.S. interest-rate cut sent markets higher. Most sectors were in the red on Friday. Consumer durables, ...
Mining has on average comprised more than 70% of group EBIT over the past five years. And as price-takers, miners like MinRes need low-cost mines with long lives and a low installed capital base to ...
Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...